ATE162946T1 - Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen - Google Patents

Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen

Info

Publication number
ATE162946T1
ATE162946T1 AT94902581T AT94902581T ATE162946T1 AT E162946 T1 ATE162946 T1 AT E162946T1 AT 94902581 T AT94902581 T AT 94902581T AT 94902581 T AT94902581 T AT 94902581T AT E162946 T1 ATE162946 T1 AT E162946T1
Authority
AT
Austria
Prior art keywords
compounds
pct
hydroxyl
contignasterol
compositions containing
Prior art date
Application number
AT94902581T
Other languages
English (en)
Inventor
Raymond J Andersen
Theresa M Allen
David L Burgoyne
Original Assignee
Univ British Columbia
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia, Univ Alberta filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE162946T1 publication Critical patent/ATE162946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94902581T 1992-12-23 1993-12-21 Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen ATE162946T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002086221A CA2086221C (en) 1992-12-23 1992-12-23 Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent

Publications (1)

Publication Number Publication Date
ATE162946T1 true ATE162946T1 (de) 1998-02-15

Family

ID=4150905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902581T ATE162946T1 (de) 1992-12-23 1993-12-21 Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen

Country Status (11)

Country Link
US (1) US5646138A (de)
EP (1) EP0675721B1 (de)
JP (1) JP3366639B2 (de)
AT (1) ATE162946T1 (de)
AU (1) AU673405B2 (de)
CA (2) CA2086221C (de)
DE (1) DE69316927T2 (de)
DK (1) DK0675721T3 (de)
ES (1) ES2114678T3 (de)
GR (1) GR3026346T3 (de)
WO (1) WO1994014451A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100368425C (zh) * 1996-07-11 2008-02-13 茵弗莱采姆药物有限公司 6，7－氧化的甾族化合物及其用途
EP1304333A3 (de) * 1996-07-11 2005-03-09 Inflazyme Pharmaceuticals, Ltd. 6,7-oxygenierte Steroide und deren Verwendung
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
MXPA02010645A (es) * 2000-04-28 2004-04-20 Inflazyme Pharm Ltd Esteroides de 3-nitrogeno-5, 7-dioxigeno y usos relacionados con los mismos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079239A (en) * 1990-02-16 1992-01-07 Harbor Branch Oceanographic Institution, Inc. Sterol disulfates and methods of use

Also Published As

Publication number Publication date
EP0675721A1 (de) 1995-10-11
DK0675721T3 (da) 1998-04-06
JPH08504773A (ja) 1996-05-21
GR3026346T3 (en) 1998-06-30
US5646138A (en) 1997-07-08
WO1994014451A1 (en) 1994-07-07
EP0675721B1 (de) 1998-02-04
ES2114678T3 (es) 1998-06-01
AU673405B2 (en) 1996-11-07
AU5691394A (en) 1994-07-19
CA2152621A1 (en) 1994-07-07
DE69316927D1 (de) 1998-03-12
JP3366639B2 (ja) 2003-01-14
CA2152621C (en) 2000-10-31
CA2086221C (en) 2003-07-15
DE69316927T2 (de) 1998-10-22
CA2086221A1 (en) 1994-06-24

Similar Documents

Publication Publication Date Title
HUP0300836A2 (hu) Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása
ITMI922699A1 (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
HUP0103781A2 (hu) Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák
AU3563695A (en) Novel piperidine derivatives with paf antagonist activity
ATE319715T1 (de) Antikonvulsive pseudofructopyranose sulfamate
FI955837A (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
DE69314779D1 (de) Prozess zur herstellung von beta-phenylisoserin und analogen verbindungen
ATE162946T1 (de) Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen
GB2266665B (en) 5-HT1-like receptor agonist for rectal administration
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
ATE185071T1 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
EP0820771A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
FI950209A (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
EP0820770A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und ein Antioxidans enthält
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
ES2107174T3 (es) Derivados del etoposido, su procedimiento de preparacion, su utilizacion a titulo de medicamento y su utilizacion para la preparacion de un medicamento destinado al tratamiento anticanceroso.
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
KR930017579A (ko) 신경 보호제
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
ATE212352T1 (de) Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate
ATE96319T1 (de) Glycyl-p-amino-pyridin zur behandlung von seniler demenz.
MY107023A (en) Antimalarial compositions
ATE155136T1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee